Related Experiment Video
Updated: Jun 19, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Preventing myocardial infarction and stroke with a simplified bundle of cardioprotective medications
R James Dudl1, Margaret C Wang, Michelle Wong
1Care Management Institute, Kaiser Permanente, Oakland, CA 94612, USA. jim.r.dudl@kp.org
Insights
Promoting a fixed-dose statin and ACEI/ARB bundle significantly reduced hospitalizations for myocardial infarction (MI) and stroke in patients with diabetes or coronary artery disease (CAD). This simplified approach improved cardiovascular outcomes in a large healthcare system.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Health Services Research
Background:
- Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality.
- Effective management of patients with diabetes and coronary artery disease (CAD) is crucial for preventing adverse cardiovascular events.
- Integrated healthcare systems offer opportunities for streamlined treatment protocols.
Purpose of the Study:
- To evaluate the impact of a simplified, fixed-dose medication bundle on cardiovascular event rates.
- To assess the effectiveness of combining a generic statin with an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB).
- To determine if minimal outpatient visits and laboratory testing enhance adherence and outcomes.
Main Methods:
- A three-year observational study involving 170,024 Kaiser Permanente members.
- Instrumental variable analysis was employed to assess the association between medication bundle promotion and hospitalization rates.
- Patients were categorized based on medication possession duration: low exposure (1-365 days) and high exposure (366-730 days).
Main Results:
- High exposure to the medication bundle was associated with a significant reduction in hospitalizations for myocardial infarction (MI) and stroke.
- A reduction of 26 events per 1000 person-years was observed in the high exposure group (95% CI = 17, 34), preventing 545 events.
- Low exposure also showed a benefit, with 15 fewer events per 1000 person-years (95% CI = 1, 30), preventing 726 events.
Conclusions:
- A simplified, fixed-dose medication bundle of statin and ACEI/ARB is effective in reducing MI and stroke hospitalizations.
- This approach was successfully implemented in a large, diverse patient population within an integrated healthcare system.
- Minimalistic clinical follow-up and laboratory testing were feasible alongside this bundled medication strategy.
Objective:
To assess the effect of promoting a bundle of fixed doses of a generic statin and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (ACEI/ARB), delivered with minimal outpatient visits, laboratory testing, and dosage titration, to people with diabetes, coronary artery disease (CAD), or both in a large integrated healthcare system.
Study Design:
Three-year observational study of 170,024 Kaiser Permanente members with diabetes, CAD, or both.
Methods:
Using instrumental variable analysis, we assessed the impact of promoting the cardioprotective bundle on hospitalization rates for stroke and myocardial infarction (MI).
Results:
In 2004 and 2005, 47,268 of 170,024 individuals received "low exposure" (medication possession on 1 to 365 days). Their risk of hospitalization for MI or stroke in 2006 was lowered by 15 events per 1000 person-years (95% confidence interval [CI] = 1, 30), preventing events in 726 people. Furthermore, 21,292 of 170,024 individuals received "high exposure" (medication possession on 366 to 730 days). Their risk of hospitalization for MI or stroke was reduced by 26 events per 1000 person-years (95% CI = 17, 34), preventing events in 545 people.
Conclusion:
A simplified method for bundling fixed doses of a generic statin and an ACEI/ARB was successfully implemented in a large, diverse population in an integrated healthcare delivery system, reducing the risk of hospitalization for MI and stroke.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy V: Interprofessional Care